Featured Articles

31. 2024 Biopharma Sustainability Review Findings 9/3/2024

    What actions are biopharma leaders worldwide taking to enhance sustainability? What challenges are they encountering? And how can the broader industry learn from the companies paving the way?

32. PUPSIT As Part Of A Contamination Control Strategy (CCS) 8/21/2024

    Learn about the changes introduced in the latest revision to EU GMP Annex 1, and gain insight into the components that should be part of a PUPSIT risk assessment.

33. When Should Filter Validation Be Performed? 8/21/2024

    Learn about a program that has been developed to facilitate risk mitigation before process-specific filter validation is performed.

34. The Scalability Of Depth Filters For CHO Cell Culture Clarification 7/19/2024

    Clarification using depth filtration is standard in monoclonal antibody (mAb) manufacturing. Here, we showcase the scalability of Stax™ mAx depth filters, demonstrating their effectiveness.

35. Is Industry Ready To Take A Bite Out Of Obesity? 7/15/2024

    What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?

36. New And Upcoming Trends In Immunodiagnostics 7/15/2024

    Explore the latest trends and cutting-edge technologies in immunodiagnostics that are transforming disease detection.

37. CAR T Set The Pace So All Can Win The Cell Therapy Race 7/15/2024

    Gain insight into the modest origins of cell therapy manufacturing and how this history has paved the way for future advancements from Bill Shingleton, R&D Leader at Cytiva.

38. When Measuring Filter Performance, Is Performance Absolute? 7/3/2024

    Learn why high-performing filters are inadequate for critical filtration processes and sterilizing-grade filters are necessary to effectively remove undesirable species, including bacteria and viruses.

39. Filtration Methods To Overcome New Challenges In Viral Safety 7/3/2024

    This study offers valuable insights to guide informed decisions in virus filtration, aligning with both the PDA TR-41 (2022) and ICH-Q5A guidelines.

40. Optimizing Virus Filtration Validation 7/3/2024

    Explore guidance regarding the effective validation of a virus filtration process in the laboratory, including the fundamentals of viral filtration and an examination of relevant regulatory guidelines.